1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,065 | 0,097 | 07:57 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.08. | hVIVO buys CRS Berlin as expands into dermatology and women's health | 23 | Alliance News | ||
| 27.08. | hVIVO übernimmt CRS Berlin: Expansion in Dermatologie und Frauengesundheit | 3 | Investing.com Deutsch | ||
| 27.08. | hVIVO acquires CRS Berlin for dermatology, women's health trials | 3 | Investing.com | ||
| 27.08. | hVIVO plc: hVIVO acquires CRS Berlin, expanding expertise into dermatology and women's health markets | 614 | GlobeNewswire (Europe) | London, UK - 27 August 2026, hVIVO plc (AIM: HVO), a purpose-built, full-service international clinical development partner and the world leader in human challenge trials, announces the acquisition... ► Artikel lesen | |
| 27.08. | hVIVO PLC - hVIVO acquires CRS Berlin | 1 | RNS | ||
| 23.07. | hVIVO PLC - H1 2026 Trading Update | - | RNS | ||
| 13.07. | hVIVO PLC - Change of Auditor | - | RNS | ||
| HVIVO Aktie jetzt für 0€ handeln | |||||
| 09.06. | hVIVO PLC - Holding(s) in Company | 1 | RNS | ||
| 01.06. | hVIVO schließt Beratungsvertrag mit Decoy Therapeutics | 2 | Investing.com Deutsch | ||
| 01.06. | hVIVO PLC - Consultancy contract with Decoy Therapeutics | - | RNS | ||
| 29.05. | hVIVO PLC - Grant of awards under Long Term Incentive Plan | - | RNS | ||
| 20.05. | hVIVO PLC - Capital Markets Day | - | RNS | ||
| 13.05. | hVIVO PLC - Result of AGM | 1 | RNS | ||
| 12.05. | hVIVO PLC - Holding(s) in Company | - | RNS | ||
| 07.05. | EARNINGS AND TRADING: MHA expects profit beat; hVIVO wins work | 1 | Alliance News | ||
| 07.05. | hVIVO signs £6m influenza clinical trial deal | 1 | Sharecast | ||
| 07.05. | hVIVO PLC - £6m Influenza HCT contract signed | - | RNS | ||
| 24.04. | hVIVO PLC - Director/PDMR Shareholding | - | RNS | ||
| 22.04. | hVIVO secures large whooping cough vaccine test contract | 1 | Sharecast | ||
| 22.04. | hVIVO PLC - HCT contract signed with ILiAD Biotechnologies | - | RNS |
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CERENOME | 2,400 | +5,73 % | Cerenome, Inc.: Cerenome Reports Second Quarter 2026 Financial Results and Business Update | HOUSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), a CNS oncology company advancing an integrated platform that combines precision diagnostics... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | Nugen Medical Devices Inc: Nugen issues corrective disclosure following OSC review | ||
| UNIDOC HEALTH | 0,051 | -11,42 % | Unidoc Health Corp: Unidoc has no material changes | ||
| NETRAMARK | 0,400 | +0,50 % | Netramark Holdings Inc: Netramark appoints Fournier as director | ||
| ASENSUS SURGICAL | - | - | Karl Storz to fully integrate Asensus, discontinue Senhance, Luna robots | ||
| JD HEALTH INTERNATIONAL | 4,184 | +1,38 % | Nomura Cuts JD HEALTH TP to HKD60; Regulatory Headwinds Mainly Concentrated in Nutrition Products Segment | ||
| MEDIVOLVE | - | - | Medivolve Inc (2): OSC cites Bharti, Said for disclosure failures | ||
| LIFEWARD | 7,260 | 0,00 % | Lifeward Ltd.: Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial Officer | HUDSON, Mass. and YOKNEAM ILLIT, Israel, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio... ► Artikel lesen | |
| IMUNON | 1,380 | 0,00 % | Imunon, Inc.: IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer | Enrollment momentum exceeding expectations is based on highly promising survival (OS) data and well tolerated safety profile demonstrated in the Company's large, randomized Phase II study, OVATION... ► Artikel lesen | |
| ROCKWELL MEDICAL | 8,020 | -0,62 % | XFRA RWM: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILROCKWELL MEDICAL... ► Artikel lesen | |
| VIRIDIAN THERAPEUTICS | 19,400 | -1,52 % | Aktien New York Ausblick: Nasdaq erholt - Comcast-Aufspaltung beflügelt Branche | NEW YORK (dpa-AFX) - Die Anleger dürften den jüngsten Kursrückschlag an der New Yorker Tech-Börse Nasdaq direkt zum Wiedereinstieg nutzen. Im Fokus stehen am Montag die jüngste Entspannung im davor... ► Artikel lesen | |
| SINTX TECHNOLOGIES | 1,520 | 0,00 % | SINTX Technologies, Inc.: SINTX Technologies Regains Compliance with Nasdaq Stockholders' Equity Requirement | SALT LAKE CITY, Utah, Aug. 13, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), a company focused on advanced silicon nitride materials and medical technologies... ► Artikel lesen | |
| AETHLON MEDICAL | 1,830 | 0,00 % | AETHLON MEDICAL INC - 8-K, Current Report | ||
| NEURONETICS | 2,430 | +1,25 % | Neuronetics Reports Second Quarter 2026 Financial and Operating Results | MALVERN, Pa., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the "Company" or "Neuronetics"), a leader in interventional mental health that combines its NeuroStar® TMS technology... ► Artikel lesen | |
| SAVARIA | 16,700 | -2,34 % | Savaria Corporation: Savaria's Second Quarter Delivers 8.4% Revenue Growth and Continued Margin Expansion | LAVAL, Québec, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Savaria Corporation ("Savaria") (TSX: SIS), one of the global leaders in the accessibility industry, is pleased to announce its results for the second... ► Artikel lesen |
HVIVO PLC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,070 Euro. Die Dividendendrendite beträgt aktuell 0,00 % (berechnet anhand der Ausschüttung von 0,00 Euro in den letzten 12 Monaten).
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HVIVO PLC finden Sie auf Wallstreet Online.